27 datasets found
-
Federal
Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2023
U.S. Department of Health & Human Services —
Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov. This dataset shows health conditions and... -
State
California Hospital Inpatient Mortality Rates and Quality Ratings
State of California —
The dataset contains risk-adjusted mortality rates, quality ratings, and number of deaths and cases for 6 medical conditions treated (Acute Stroke, Acute Myocardial... -
State
Rates of Preventable Hospitalizations for Selected Medical Conditions by County (LGHC Indicator)
State of California —
The dataset contains hospitalization counts and rates, statewide and by county, for 10 ambulatory care sensitive conditions plus 4 composite measures.... -
Federal
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
U.S. Department of Health & Human Services —
Cell transplantation to repair or regenerate injured myocardium is a new frontier in the treatment of cardiovascular disease. Even though it is based on many years of... -
Federal
Short-term PM2.5 exposure and early-readmission risk in Heart Failure Patients
U.S. Environmental Protection Agency —
In this manuscript EPA researchers used high resolution (1x1 km) modeled air quality data from a model built by Harvard collaborators to estimate the association... -
State
California Statewide Inpatient Mortality Rates
State of California —
The dataset contains risk-adjusted mortality rates, and number of deaths and cases for 6 medical conditions treated (Acute Stroke, Acute Myocardial Infarction, Heart... -
State
California Hospital Performance Ratings
State of California —
The dataset provides performance ratings for coronary artery bypass graft (CABG) surgery, inpatient mortality indicators (IMIs), and elective percutaneous coronary... -
Federal
Weekly Counts of Death by Jurisdiction and Select Causes of Death
U.S. Department of Health & Human Services —
Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov. This visualization provides weekly data on the... -
Federal
Pacing in congestive heart failure
U.S. Department of Health & Human Services —
Despite the major advances in medical drug therapy, heart failure remains a syndrome associated with high mortality and morbidity. Biventricular or left ventricular... -
Federal
Cytokines as new treatment targets in chronic heart failure
U.S. Department of Health & Human Services —
Inflammatory cytokines may negatively influence contractility and contribute to the remodelling process in the failing myocardium. Traditional cardiovascular drugs... -
Federal
Associations between source-apportioned PM2.5 and 30-day readmissions in heart failure patients
U.S. Environmental Protection Agency —
The dataset contains electronic health records from heart failure patients within information on hospital readmissions, residential location, air pollution exposure,... -
Federal
Infective endocarditis: too ill to be operated?
U.S. Department of Health & Human Services —
Infective endocarditis remains a disease associated with high mortality in certain groups of patients, with death resulting primarily from central nervous system... -
Federal
Prescribed Fires, Smoke Exposure, and Hospital Utilization Among Heart Failure Patients
U.S. Environmental Protection Agency —
This dataset contains data on hospital utilization, prescribed fire occurrence, and wildfire smoke exposure for heart failure patients contained within the EPA CARES... -
Federal
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
U.S. Department of Health & Human Services —
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death? -
Federal
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
U.S. Department of Health & Human Services —
Previous trials (Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure [MERIT-HF], Cardiac Insufficiency Bisoprolol Study [CIBIS] II) have... -
State
Physician Supply and Preventable Hospitalizations by County - Anticipated Retirement of Practicing Physicians
State of California —
These datasets contain hospitalization rates for seven prevention quality indicators (PQIs) and supply rates for physicians who treat these conditions per county. The... -
Federal
Beta-Adrenergic gene therapy for cardiovascular disease
U.S. Department of Health & Human Services —
Gene therapy using in vivo recombinant adenovirus-mediated gene transfer is an effective technique that offers great potential to improve existing drug treatments for... -
Federal
ELITE II and Val-HeFT are different trials: together what do they tell us?
U.S. Department of Health & Human Services —
The Losartan Heart Failure Survival Study (ELITE II) and the Valsartan Heart Failure Trial (Val-HeFT) both evaluated the efficacy and tolerability of a selective... -
Federal
Dose response of ACE inhibitors: implications of the SECURE trial
U.S. Department of Health & Human Services —
The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important one. The available evidence suggests that in chronic heart failure as well... -
Federal
Biventricular pacing in heart failure: update on results from clinical trials
U.S. Department of Health & Human Services —
Biventricular pacing or resynchronisation therapy is a non-pharmacological therapy for patients with chronic heart failure. Since being originally described in 1994,...
27 datasets found